- Drugs
- Friday, 22 May 2020
Hikma receives FDA approval for its generic Vascepa®
Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, has announced that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the US Food and Drug Administration (FDA) for its Icosapent Ethyl Capsules, 1 gm, the generic equivalent to Vascepa®1.
In March 2020, the United States District Court for the District of Nevada invalidated six key Vascepa® patents owned by Amarin. The District Court decision is currently being appealed.
Brian Hoffmann, President of Generics said, "The approval for our generic version of Vascepa® is an important milestone towards bringing this product to market. This approval demonstrates the strength of our regulatory capabilities and our commitment to provide patients and healthcare providers in the US with the high-quality medicines they need."
| Enquiries | |
| Hikma Pharmaceuticals PLC | |
| Susan Ringdal | +44 (0)20 7399 2760/ +44 7776 477050 |
| EVP, Strategic Planning and Global Affairs | |
| Steve Weiss | +1 732 720 2830/ +1 732 788 8279 |
| David Belian | +1 732 720 2814/+1 848 254 4875 |
| US Communications and Public Affairs |
Related Industry Updates
Europe Small Molecule Drug Delivery Market: Industry Overview, Trends and Growth Opportunities Forecasted Till 2027
Aug 25, 2020
Amid bitter trade war, U.S. companies pledge millions of dollars in aid
Feb 07, 2020
North America Feminine Hygiene Products market size, share, Growth and Forecasts to 2027, Key Players are Procter & Gamble, Edgewell Personal Care, Bodywise (UK) Limited, Unicharm Corporation
Nov 30, 2020
Breast Cancer Therapeutics Market is expected to reach US$ 63,967.05 million by 2030
Oct 04, 2023
North America Radiopharmaceutical Theragnostic Market is expected to reach US$ 1,529.88 million by 2028
Mar 13, 2023
Asia Pacific Starch Softgel Capsules Market Size, Share, Demand, Analysis and Forecast To 2027 | Hunan Er-Kang Pharmaceutical Co. Ltd,Softcaps,Fuji Capsule Co. Ltd.,Aenova Holding GmbH,Sirio Pharma Co. Ltd.
Oct 15, 2020
Pharmaceutical Waste Disposal and Management Market is expected to reach US$ 6,377.95 million by 2030
Jan 10, 2024
Follow us on
